Table 4.
Withdrawal severity after psychedelic-associated cannabis cessation or reduction in comparison with previous quit attempts. (n = 166).
| Withdrawal Symptom | n a | Symptom Severity | ||||
|---|---|---|---|---|---|---|
| Much less severe | Less severe | Same | More severe | Much more severe | ||
| n (%) | n (%) | n (%) | n (%) | n (%) | ||
| Lack of appetite | 75 | 18 (24.0%) | 13 (17.3%) | 31 (41.3%) | 12 (16.0%) | 1 (1.3%) |
| Fatigue | 87 | 24 (27.6%) | 20 (23.0%) | 30 (34.5%) | 7 (8.0%) | 6 (6.9%) |
| Headaches | 70 | 19 (27.1%) | 15 (21.4%) | 25 (35.7%) | 11 (15.7%) | 0 (.0%) |
| Drowsiness | 72 | 19 (26.4%) | 16 (22.2%) | 24 (33.3%) | 11 (15.3%) | 2 (2.8%) |
| Fever | 24 | 4 (16.7%) | 2 (8.3%) | 17 (70.8%) | 0 (.0%) | 1 (4.2%) |
| Nausea | 34 | 8 (23.5%) | 6 (17.6%) | 17 (50.0%) | 3 (1.8%) | 0 (.0%) |
| Tremors | 41 | 11 (26.8%) | 6 (14.6%) | 16 (39.0%) | 6 (14.6%) | 2 (4.9%) |
| Increased heart rate | 45 | 11 (24.4%) | 10 (22.2%) | 16 (35.6%) | 4 (8.9%) | 4 (8.9%) |
| Chills | 35 | 9 (25.7%) | 4 (11.4%) | 16 (45.7%) | 5 (14.3%) | 1 (2.9%) |
| Seizures | 18 | 3 (16.7%) | 1 (5.6%) | 14 (77.8%) | 0 (.0%) | 0 (.0%) |
| Hallucinations | 30 | 4 (13.3.%) | 3 (10.0%) | 13 (43.3%) | 7 (23.3%) | 3 (10.0%) |
| Cravings | 110 | 62 (56.4%) | 20 (18.2%) | 17 (15.5%) | 6 (5.5%) | 5 (4.5%) |
| Depression | 113 | 45 (39.8%) | 23 (20.4%) | 20 (17.7%) | 15 (13.3%) | 10 (8.8%) |
| Confusion | 70 | 23 (32.9%) | 13 (18.6%) | 17 (24.3%) | 9 (12.9%) | 8 (11.4%) |
| Heart pounding | 49 | 17 (34.7%) | 4 (8.2%) | 16 (32.7%) | 7 (14.3%) | 5 (10.2%) |
| Difficulty concentrating | 100 | 32 (32.0%) | 25 (25.0%) | 22 (22.0%) | 10 (10.0%) | 11 (11.0%) |
| Irritability | 94 | 30 (31.9%) | 27 (28.7%) | 17 (18.1%) | 15 (18.1%) | 5 (5.3%) |
| Insomnia | 110 | 32 (29.1%) | 17 (15.5%) | 26 (23.6%) | 21 (19.1%) | 14 (12.7%) |
| Restlessness | 95 | 27 (28.4%) | 22 (23.2%) | 23 (24.2%) | 17 (17.9%) | 6 (6.3%) |
| Anxiety | 100 | 28 (28.0%) | 27 (27.0%) | 20 (20.0%) | 12 (12.0%) | 13 (13.0%) |
a
Sample size varies by symptom (range = 18–113), as some participants had never experienced particular withdrawal symptoms. Percentages were calculated based on the number of individuals who reported a particular withdrawal symptom.
Modal responses shown in bold type.